First quarter results 2014 for Medistim ASA
First quarter results 2014 for Medistim ASA
Sales for the quarter ended at MNOK 48.9 (MNOK 45.5)
and operating profit (EBIT) ended at MNOK 7.2 (MNOK
7.3). It was a strong development in imaging sales
with a 67 % increase in capital sales. Sales of own
products increased with 31 % in Europe. The General
Assembly decided a dividend of NOK 0.80 per share
(NOK 1.10).